Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Healthy lifestyle behaviors may lower risk for dementia in type 2 diabetes
Living a healthier lifestyle can lower the risk for dementia for adults with type 2 diabetes, according to a speaker at the European Association for the Study of Diabetes annual meeting.
Balanced diet associated with better cognitive function
Maintaining a balanced energy intake through diet was associated with significantly better cognitive function compared with uneven intake patterns, researchers reported in Life Metabolism.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Resiliency 'isn't the answer' to physician burnout
CHICAGO — When struggling with burnout, many health care providers are expected to simply be more resilient, but this does not address the system creating these problems, according to two speakers.
Phase 2 trial of therapeutic for patients with early AD yields positive results
Alzheon Inc. reported statistically significant and clinically relevant results in patients with Alzheimer’s disease following 12 months of treatment with the oral investigational therapeutic ALZ-801 in its phase 2 trial.
Patients with AS receiving TNF inhibitors have lower rates of Alzheimer’s disease
Although ankylosing spondylitis correlates with higher rates of Alzheimer’s disease, patients who receive TNF inhibitors are less likely to develop the neurologic disorder, according to data published in Pharmacological Research.
Metabolites associated with sugary diet linked to cognitive function in older adults
Six metabolites — four related to sugar — were consistently associated with lower global cognitive function, researchers reported in Alzheimer’s & Dementia.
Monkeypox linked to encephalitis, confusion, seizures
Preliminary evidence suggests there is an association between monkeypox and neuropsychiatric complications, including encephalitis, confusion and seizures, a study published in EClinicalMedicine found.
Phase 2a cognition, dementia treatment trial underway
CuraSen Therapeutics Inc. announced it has begun dosing patients in a phase 2a clinical trial with CST-2032, an oral therapeutic for treatment of mild cognitive impairment or mild dementia due to either Parkinson’s or Alzheimer’s disease.
NIH awards Cedars-Sinai $8M for AI-based Alzheimer's research
Cedars-Sinai’s department of computational biomedicine has been awarded an $8 million NIH grant to use artificial intelligence methods to identify genetic predictors of Alzheimer's disease.
FDA grants accelerated approval for gene therapy to treat cerebral adrenoleukodystrophy
The FDA granted accelerated approval to bluebird bio Inc for elivaldogene autotemcel, its gene therapy that aims to slow progression of neurologic dysfunction in boys aged 4 to 17 with early, active cerebral adrenoleukodystrophy, or CALD.
-
Headline News
Suicide attempts fall sharply after screening initiative during primary care visits
October 02, 20242 min read -
Headline News
Hypothyroidism does not worsen rate of cognitive decline for perimenopausal women
October 02, 20242 min read -
Headline News
Dual therapy can have ‘synergistic effect’ in difficult-to-treat inflammatory diseases
October 01, 20242 min read
-
Headline News
Suicide attempts fall sharply after screening initiative during primary care visits
October 02, 20242 min read -
Headline News
Hypothyroidism does not worsen rate of cognitive decline for perimenopausal women
October 02, 20242 min read -
Headline News
Dual therapy can have ‘synergistic effect’ in difficult-to-treat inflammatory diseases
October 01, 20242 min read